publication date: Jun. 7, 2019

Conversation with The Cancer Letter

ASCO’s Miller: mCODE will improve downstream analytics with essential cancer data elements

Robert_Miller_2016 (1)

Robert S. Miller

Medical director, CancerLinQ®


The mCODE initiative, developed by American Society of Clinical Oncology and its partners, aims to optimize electronic health records to answer research questions on drug efficacy and patient outcomes.

The project, Minimal Common Oncology Data Elements, provides a list of data standards that can be incorporated within existing EHR systems—without reinventing the wheel, said  Robert Miller, medical director of ASCO’s CancerLinQ.

“I think our expectation is that by coalition-building, the oncology community would come together, and the potential value of a standardized solution like this would become apparent to all, and that vendors and other implementers would see the value and do this without a legislative fix,” Miller said.

“We tried to find the sweet spot with mCODE, which is to say that we know that if we built a very clunky, heavy, millions-of-data-elements data standard that would require clinicians to spend even more time entering data into the EHR, it wasn’t going to be successful.

“So, we emphasize the ‘m’ in mCODE, which is minimal, which is saying these are the most important things that everyone should do.”


Miller spoke with Paul Goldberg, editor and publisher of The Cancer Letter.


Paul Goldberg:

Continue reading ASCO’s Miller: mCODE will improve downstream analytics with essential cancer data elements
To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.